![Robby Booth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Robby Booth
Sociétés | Poste | Début | Fin |
---|---|---|---|
Glytec LLC
![]() Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences. | Directeur Technique/Scientifique/R&D | 01/01/2006 | - |
Fondateur | 01/01/2006 | - |
Historique de carrière de Robby Booth
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorielle
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Glytec LLC
![]() Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences. | Technology Services |
- Bourse
- Insiders
- Robby Booth
- Expérience